Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the ...

The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...

Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. For eligible patients, liver surgery or hepatectomy is an effective treatment option. However, ...

CDR-Life announces early clinical data demonstrating pharmacodynamic activity of CDR404: Zurich, Switzerland Saturday, October 25, 2025, 18:00 Hrs [IST] CDR-Life, Inc, a biotechno ...

Research shows CRATERs correlate with immunotherapy success, boosting CD8+ T cells in melanoma. Find out how this discovery ...

Ziftomenib in relapsed/refractory (R/R) NPM1-mutant acute myeloid leukemia (AML): Phase 1b/2 clinical activity and safety results from the pivotal KOMET-001 study. This is an ASCO Meeting Abstract ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Meet the Jekyll and Hyde of the immune system: activated CD8⁺ T cells. On June 24 in Nature Immunology, researchers led by Dorian McGavern at the National Institutes of Health introduce a granzyme ...

Confirmation of 30mg efti as optimal biological dose relevant for Immutep’s oncology pipeline and potential future Biological ...

By examining the cells at single-cell resolution, the researchers identified a minor subset of tumor-cytotoxic ... and ...